201 Premature placental aging in term small for gestational age and fetal growth restriction OBJECTIVE: From early to term pregnancy, the placenta normally presents progressive aging promoting cell death leading to decreased activity related to normal post-term changes. While previous studies in placentas from small fetuses suggested an accelerated placental aging process, it is unclear whether SGA -with apparent normal placental function by ultrasound-encompass premature placental aging or whether this phenomenon is restricted to FGR. The aim of this study was to perform a comprehensive assessment of the placental aging process through senescence and apoptotic markers in late-onset small fetuses classified as SGA or FGR. STUDY DESIGN: A nested case-control study in singleton pregnancies delivering at term including 21 normally grown fetuses and 36 small fetuses classified into SGA (if birthweight was between the 3rd and 9th centile and normal fetoplacental Doppler; n¼18) and FGR (if birthweight <3rd centile and/or abnormal cerebroplacental ratio or uterine artery Doppler; n¼18). Telomerase activity, telomere length and RNA expression of senescence (Sirtuin 1,3,6) and apoptotic markers (p53, p21, BAX, Caspase 3 and 9) were analyzed in placental samples collected at birth. RESULTS: Compared with normally grown fetuses, both SGA and FGR presented signs of accelerated placental aging including lower telomerase activity (controls meanAESD 12.8% AE 6.6 vs SGA 7.98% AE 4.2 vs FGR 7.79% AE 4.6, p¼0.008), shorter telomeres (controls 1.20 T/S AE 0.6 vs SGA 1.08 T/S AE 0.9 vs FGR 0.66 T/S AE 0. 
